Tag: anemia of chronic disease

What is vadadustat?1 The FDA approved vadadustat (Vafseo®) in March 2024 for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is only approved for dialysis dependent CKD patients. It is not indicated to replace blood transfusions. What is vadadustat’s mechanism of action? Vadadustat is a hypoxia-inducible factor prolyl hydroxylase (HIF PF) inhibitor.…